Relationship of cerebrospinal fluid markers to 11C-PiB and 18F-FDDNP binding

Journal of Nuclear Medicine

Volumn 50, Issue 9, 2009, Pages 1464-1470

  Tolboom, Nelleke ^a,b   Van Der Flier, Wiesje M ^a,b   Yaqub, Maqsood ^a   Boellaard, Ronald ^a   Verwey, Nicolaas A ^a,b   Blankenstein, Marinus A ^a   Windhorst, Albert D ^a   Scheltens, Philip ^b   Lammertsma, Adriaan A ^a   Van Berckel, Bart N M ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

11C PiB, pittsburgh compound B; 18F FDDNP; Alzheimer; CSF; PET; Tau

Indexed keywords

2 (1 [6 [(2 FLUOROETHYL)(METHYL)AMINO 2 NAPHTHYL]ETHYLIDENE]MALONONITRILE F 18; AMYLOID BETA PROTEIN[1-42]; PITTSBURGH COMPOUND B C 11; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

AGED; ALZHEIMER DISEASE; ARTICLE; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG BINDING; FEMALE; HUMAN; LUMBAR PUNCTURE; MALE; MILD COGNITIVE IMPAIRMENT; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

AGED; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; BENZOTHIAZOLES; BIOLOGICAL MARKERS; BRAIN; COGNITION DISORDERS; FEMALE; HUMANS; MALE; NITRILES; PEPTIDE FRAGMENTS; POSITRON-EMISSION TOMOGRAPHY; PROTEIN BINDING; RADIOPHARMACEUTICALS; STATISTICS AS TOPIC; TAU PROTEINS; TISSUE DISTRIBUTION;

EID: 69449085355     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.109.064360     Document Type: Article

References (33)

1. Klunk WE, Engler H, Nordberg A, et al. Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. Ann Neurol. 2004;55:306-319. (Pubitemid 38269583)
2. Small GW, Kepe V, Ercoli LM, et al. PET of brain amyloid and tau in mild cognitive impairment. N Engl J Med. 2006;355:2652-2663. (Pubitemid 44969124)
3. Blennow K, Hampel H. CSF markers for incipient Alzheimer's disease. Lancet Neurol. 2003;2:605-613. (Pubitemid 37162569)
4. Klunk WE, Lopresti BJ, Ikonomovic MD, et al. Binding of the positron emission tomography tracer Pittsburgh compound-B reflects the amount of amyloid-β in Alzheimer's disease brain but not in transgenic mouse brain. J Neurosci. 2005;25:10598-10606.
5. Klunk WE, Wang Y, Huang GF, et al. The binding of 2-(4′- methylaminophenyl) benzothiazole to postmortem brain homogenates is dominated by the amyloid component. J Neurosci. 2003;23:2086-2092. (Pubitemid 36368896)
6. Ikonomovic MD, Klunk WE, Abrahamson EE, et al. Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease. Brain. 2008;131:1630-1645.
7. Agdeppa ED, Kepe V, Liu J, et al. Binding characteristics of radiofluorinated 6-dialkylamino-2-naphthylethylidene derivatives as positron emission tomography imaging probes for β-amyloid plaques in Alzheimer's disease. J Neurosci. 2001;21:RC189.
8. 42 in humans. Ann Neurol. 2006;59:512-519.
9. 42 ratio as a prediction of cognitive decline in nondemented older adults. Arch Neurol. 2007;64:343-349.
10. Forsberg A, Engler H, Almkvist O, et al. PET imaging of amyloid deposition in patients with mild cognitive impairment. Neurobiol Aging. 2008;29:1456-1465.
11. 11C]PIB uptake and cerebrospinal fluid β-amyloid in mild cognitive impairment. Dement Geriatr Cogn Disord. 2008;26:378-383.
12. Grimmer T, Riemenschneider M, Forstl H, et al. Beta amyloid in Alzheimer's disease: increased deposition in brain is reflected in reduced concentration in cerebrospinal fluid. Biol Psychiatry. 2009;65:927-934.
13. 18F-FDDNP positron emission tomography. J Nucl Med. 2009;50:191-197.
14. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984;34:939-944. (Pubitemid 14076461)
15. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol. 1999;56:303-308. (Pubitemid 29120227)
16. 18F] fluoroethyl) (methyl)amino]-2-naphthyl]ethylidene)malono nitrile. Neuroscience. 2003;117:723-730.
17. Brix G, Zaers J, Adam LE, et al. Performance evaluation of a whole-body PET scanner using the NEMA protocol. National Electrical Manufacturers Association. J Nucl Med. 1997;38:1614-1623.
18. 11C]PIB studies in Alzheimer's disease. Eur J Nucl Med. April 29, 2009 [Epub ahead of print].
19. 11C]-6-OH-BTA-1). J Labelled Comp Radiopharm. 2004;47:679-682.
20. 18F]FDDNP). Appl Radiat Isot. 2008;66:203-207.
21. Maes F, Collignon A, Vandermeulen D, Marchal G, Suetens P. Multimodality image registration by maximization of mutual information. IEEE Trans Med Imaging. 1997;16:187-198. (Pubitemid 127762930)
22. Svarer C, Madsen K, Hasselbalch SG, et al. MR-based automatic delineation of volumes of interest in human brain PET images using probability maps. Neuroimage. 2005;24:969-979. (Pubitemid 40164499)
23. Wu Y, Carson RE. Noise reduction in the simplified reference tissue model for neuroreceptor functional imaging. J Cereb Blood Flow Metab. 2002;22:1440-1452. (Pubitemid 35424928)
24. 11C]PIB studies. Neuroimage. 2008;42:76-86.
25. 18F]FDDNP studies. Mol Imaging Biol. April 2, 2009 [Epub ahead of print].
26. Innis RB, Cunningham VJ, Delforge J, et al. Consensus nomenclature for in vivo imaging of reversibly binding radioligands. J Cereb Blood Flow Metab. 2007;27:1533-1539. (Pubitemid 47301451)
27. Yamaguchi H, Hirai S, Morimatsu M, Shoji M, Nakazato Y. Diffuse type of senile plaques in the cerebellum of Alzheimer-type dementia demonstrated by beta protein immunostain. Acta Neuropathol. 1989;77:314-319. (Pubitemid 19044199)
28. Joachim CL, Morris JH, Selkoe DJ. Diffuse senile plaques occur commonly in the cerebellum in Alzheimer's disease. Am J Pathol. 1989;135:309-319. (Pubitemid 19240215)
29. Bouwman FH, van der Flier WM, Schoonenboom NS, et al. Longitudinal changes of CSF biomarkers in memory clinic patients. Neurology. 2007;69:1006-1011.
30. Thompson PW, Ye L, Morgenstern JL, et al. Interaction of the amyloid imaging tracer FDDNP with hallmark Alzheimer's disease pathologies. J Neurochem. 2009;109:623-630.
31. de Leon MJ, Convit A, George AE, et al. In vivo structural studies of the hippocampus in normal aging and in incipient Alzheimer's disease. Ann N Y Acad Sci. 1996;777:1-13. (Pubitemid 26149164)
32. Meltzer CC, Leal JP, Mayberg HS, Wagner HN Jr, Frost JJ. Correction of PET data for partial volume effects in human cerebral cortex by MR imaging. J Comput Assist Tomogr. 1990;14:561-570.
33. 11C](R)-PK11195 studies [abstract]. Neuroimage. 2006;31(suppl 2):T83.